MedPath
HSA Approval

CEFAZOLIN SANDOZ 1 g/vial

SIN07879P

CEFAZOLIN SANDOZ 1 g/vial

CEFAZOLIN SANDOZ 1 g/vial

October 21, 1994

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

J01DB04

cefazolin

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

SANDOZ GMBH

Active Ingredients

CEFAZOLIN SODIUM EQV CEFAZOLIN

1 g/vial

Cefazolin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CEFAZOLIN SANDOZ 1 g/vial - HSA Approval | MedPath